
Heidelberg Pharma AG
XETRA:HPHA

Wall Street
Price Targets
HPHA Price Targets Summary
Heidelberg Pharma AG
According to Wall Street analysts, the average 1-year price target for
HPHA
is 12.14 EUR
with a low forecast of 12.02 EUR and a high forecast of 12.5 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HPHA's stock price target?
Price Target
12.14
EUR
According to Wall Street analysts, the average 1-year price target for
HPHA
is 12.14 EUR
with a low forecast of 12.02 EUR and a high forecast of 12.5 EUR.
What is Heidelberg Pharma AG's Revenue forecast?
Projected CAGR
14%
For the last 7 years the
compound annual growth rate for
Heidelberg Pharma AG's revenue is
33%.
The projected
CAGR
for the next 3 years is
14%.